1_img1424895986.jpg 2_img1424896008.jpg 3_img1424896028.jpg 4_img1424896053.jpg
ГЛЕДФАРМ ЛТД intro pharmacovigilance logo-img
  • 1-img1423128723_img1424877095.jpg
  • 2-img1423128732_img1424877082.jpg
  • 3-img1423128813_img1424877070.jpg
  • 4-img1423128825_img1424877057.jpg
  • analiz111_img1422534233.jpg

“Actovegin” is manufactured at "Kusum Pharm" now

21.11.2011

21.04.2011 at “Kusum Pharm” plant it was hold a presentation of a joint project of “Kusum Pharm” LLC and “Nycomed“ international pharmaceutical company. At the Ukrainian plant it was started the process of packing of known “Actovegin” medicine, which is widely used to treat acute and chronic strokes, consequences of stroke, traumatic brain injury and dementia. “Kusum Pharm” pharmaceutical plant successfully passed the procedure of a comprehensive audit carried out by Austrian inspectors, and it was confirmed its compliance with European standards of GMP manufacturing. According to new scheme of manufacturing this medicine in capsules and bottles will be delivered to Ukraine from the country-manufacturer – Austria, packed and underwent quality control at certified according to European GMP standards “Kusum Pharm” enterprise in Sumy.

It is expected that this step will lead to an uninterrupted supply of medicine into pharmacies and make it more available.

At presentation of the beginning of the project the following persons were present: Head of Sumy Regional State Administration, Yuriy Chmyr, Head of “Nycomed” company in Ukraine and Moldova, Eugene Zaika, General Director of “Kusum Pharm” LLC, Rajeev Gupta, and president of “Sumy scientific production association by Frunze”JSC, a Hero of Ukraine, Vladimir Lukyanenko.